LUPO, Antonio
 Distribuzione geografica
Continente #
NA - Nord America 13.376
EU - Europa 12.240
AS - Asia 8.735
SA - Sud America 1.234
AF - Africa 165
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 14
Totale 35.785
Nazione #
US - Stati Uniti d'America 13.197
RU - Federazione Russa 4.088
SG - Singapore 3.721
GB - Regno Unito 2.943
CN - Cina 2.600
BR - Brasile 1.000
SE - Svezia 929
IT - Italia 918
VN - Vietnam 768
DE - Germania 756
FR - Francia 741
IE - Irlanda 681
FI - Finlandia 657
HK - Hong Kong 642
KR - Corea 315
UA - Ucraina 219
IN - India 120
AR - Argentina 91
CA - Canada 77
JP - Giappone 76
BD - Bangladesh 67
ID - Indonesia 65
TR - Turchia 62
IQ - Iraq 53
MX - Messico 53
BE - Belgio 50
NL - Olanda 43
AT - Austria 41
NG - Nigeria 41
EC - Ecuador 38
ZA - Sudafrica 38
ES - Italia 33
PL - Polonia 32
CO - Colombia 27
IL - Israele 25
VE - Venezuela 24
UZ - Uzbekistan 23
MA - Marocco 22
PK - Pakistan 22
AU - Australia 19
PY - Paraguay 18
EG - Egitto 17
AE - Emirati Arabi Uniti 16
CL - Cile 16
SA - Arabia Saudita 16
PH - Filippine 14
MY - Malesia 13
TH - Thailandia 13
AZ - Azerbaigian 12
CZ - Repubblica Ceca 11
EU - Europa 11
GR - Grecia 10
JO - Giordania 10
LT - Lituania 10
TN - Tunisia 10
CH - Svizzera 9
KZ - Kazakistan 9
RO - Romania 9
BH - Bahrain 8
JM - Giamaica 8
KE - Kenya 8
NP - Nepal 8
PA - Panama 8
BO - Bolivia 7
HR - Croazia 7
PE - Perù 7
AL - Albania 6
IR - Iran 6
KG - Kirghizistan 6
NI - Nicaragua 6
OM - Oman 6
PS - Palestinian Territory 6
RS - Serbia 6
CR - Costa Rica 5
DK - Danimarca 5
DO - Repubblica Dominicana 5
ET - Etiopia 5
HN - Honduras 5
KH - Cambogia 5
LV - Lettonia 5
PT - Portogallo 5
SN - Senegal 5
UY - Uruguay 5
CG - Congo 4
DZ - Algeria 4
HU - Ungheria 4
LB - Libano 4
SV - El Salvador 4
TW - Taiwan 4
AM - Armenia 3
BG - Bulgaria 3
BY - Bielorussia 3
LA - Repubblica Popolare Democratica del Laos 3
LK - Sri Lanka 3
NO - Norvegia 3
SK - Slovacchia (Repubblica Slovacca) 3
SY - Repubblica araba siriana 3
TT - Trinidad e Tobago 3
XK - ???statistics.table.value.countryCode.XK??? 3
BB - Barbados 2
Totale 35.750
Città #
Southend 2.455
Singapore 1.982
Jacksonville 1.891
Chandler 1.442
Ashburn 1.366
Moscow 1.246
San Jose 1.031
Woodbridge 901
Dallas 784
Ann Arbor 714
Dublin 678
Hong Kong 634
Houston 544
Verona 400
The Dalles 378
Beijing 366
Wilmington 284
Lawrence 268
Princeton 268
New York 205
Jinan 198
Ho Chi Minh City 196
Los Angeles 175
Nanjing 173
Shenyang 166
Hanoi 147
Buffalo 133
Helsinki 132
Boardman 119
Tianjin 115
Hebei 106
Dong Ket 101
São Paulo 97
Sindelfingen 89
Columbus 83
Council Bluffs 82
Santa Clara 72
Tokyo 72
Milan 71
Ningbo 66
Changsha 64
Haikou 63
Guangzhou 62
Orem 62
Zhengzhou 62
Redondo Beach 61
Nanchang 58
Munich 55
Jiaxing 52
Brussels 50
Hangzhou 50
Seattle 48
Lancaster 47
Taizhou 44
Falls Church 41
Seoul 40
Abuja 39
Taiyuan 38
Jakarta 37
San Francisco 37
Philadelphia 35
Rio de Janeiro 35
Norwalk 34
Chicago 33
Lanzhou 33
London 32
Chennai 29
Nuremberg 29
Rome 28
Turku 28
Frankfurt am Main 27
Montreal 27
Auburn Hills 26
Vienna 26
Warsaw 26
Washington 26
Atlanta 25
Phoenix 25
Brooklyn 24
Denver 23
Kent 23
Toronto 23
Da Nang 22
Haiphong 22
Baghdad 21
Detroit 21
Johannesburg 21
Quito 21
Redmond 21
Amsterdam 20
Fuzhou 20
Fairfield 19
Redwood City 18
Venice 18
Belo Horizonte 17
Biên Hòa 17
Mumbai 17
Tashkent 17
Dhaka 16
Hải Dương 16
Totale 22.201
Nome #
125I-iothalamate and creatinine clearances in patients with chronic renal diseases 284
DISREGOLAZIONE DELLA BIOSINTESI E DEL METABOLISMO DEI PROTEOGLICANI/GLICOSAMINOGLICANI NEI SOGGETTI UREMICI: UNO STUDIO DI GENOMICA FUNZIONALE 256
Eparanasi: un nuovo biomarker di fibrosi e un potenziale target farmacologico per ridurre la progressione del danno renale cronico 252
Low platelet glutathione peroxidase activity and serum selenium concentration in patients with chronic renal failure: relations to dialysis treatments, diet and cardiovascular complications 249
Adding access blood flow surveillance to clinical monitoring reduces thrombosis rates and costs, and improves fistula patency in the short term: a controlled cohort study. 220
Endovascular versus Surgical Preemptive Repair of Forearm Arteriovenous Fistula Juxta-Anastomotic Stenosis: Analysis of Data Collected Prospectively from 1999 to 2004 214
A randomized study comparing methylprednisolone plus chlorambucil versus methylprednisolone plus cyclophosphamide in idiopathic membranous nephropathy. 208
A napkin-associated outbreak of Burkholderia cenocepacia bacteraemia in haemodialysis patients. 208
A single dialysis session of hemodiafiltration with sorbent-regenerated endogenous ultrafiltrate reinfusion (HFR) removes hepcidin more efficiently than bicarbonate hemodialysis: a new approach to containing hepcidin burden in dialysis patients? 205
Terapia della glomerulonefrite membrano proliferativa. 204
Long-Term (3 Years) Prognosis of Contrast-Induced Acute Kidney Injury After Coronary Angiography 204
IDENTIFICATION OF MOLECULAR BIOMARKERS FOR EARLY DIAGNOSIS OF DELAYED GRAFT FUNCTION IN RENAL TRANSPLANT RECIPIENTS 203
A prospective, randomized trial of two antibiotic regimens in the treatment of peritonitis in CAPD patients: Teicoplanin plus tobramycin versus cephalothin plus tobramycin 202
14-year experience with the double-cuff straight Tenckhoff catheter 200
A new mechanism of action of sulodexide in diabetic nephropathy: inhibits heparanase-1 and prevents FIG-2-induced renal epithelial-mesenchymal transition. 199
Cutaneous plasmacytoma in a hemodialysis patient. 197
A specific immune transcriptomic profile discriminates chronic kidney disease patients in predialysis from hemodialyzed patients. 196
Alterations in renal tubular sodium and water transport in polycystic kidney disease 193
Outcomes of the surgical revision of stenosed and thrombosed forearm arteriovenous fistulae for hemodialysis 193
Hairy cell leukemia in kidney transplantation: lesson from a rare disorder. 191
Comparison of serum creatinine and cystatin C for early diagnosis of contrast-induced nephropathy after coronary angiography and interventions. 190
In Vitro Identification of New Transcriptomic and miRNomic Profiles Associated with Pulmonary Fibrosis Induced by High Doses Everolimus: Looking for New Pathogenetic Markers and Therapeutic Targets. 185
Anaemia in diabetic renal failure: is there a role for early erythropoietin treatment in preventing cardiovascular mortality? 185
Aspects of calcium metabolism in obstructive nephropathy: a metabolic and bone biopsy investigation 184
mTOR inhibitors and renal allograft: Yin and Yang. 184
IDENTIFICAZIONE DI BIOMARCATORI MOLECOLARI PER LA DIAGNOSI PRECOCE DELLA FUNZIONALITÀ RITARDATA DELL'ORGANO TRAPIANTATO 182
Early creatinine shifts predict contrast-induced nephropathy and persistent renal damage after angiography. 180
Downregulation of nuclear-encoded genes of oxidative metabolism in dialyzed chronic kidney disease patients. 180
NLRP3 Inflammasome Activation in Dialyzed Chronic Kidney Disease Patients. 180
99mTc-Ca-gluconate renal scintigraphy in patients with chronic renal failure 179
An unusual association of contralateral congenital small kidney, reduced renal function and hyperparathyroidism in sponge kidney patients: on the track of the molecular basis. 178
The relationship between calcium kidney stones, arterial stiffness and bone density: unraveling the stone-bone-vessel liaison 178
Everolimus-associated interstitial pneumonia in a renal transplant patient: a case report 177
Proteomic-based research strategy identified laminin subunit alpha 2 as a potential urinary-specific biomarker for the medullary sponge kidney disease. 177
Everolimus-induced epithelial to mesenchymal transition (EMT) in bronchial/pulmonary cells: when the dosage does matter in transplantation 177
Specific heparanase inhibition reverses glucose-induced mesothelial-to-mesenchymal transition. 176
Extra-renal adverse effects of mTOR inhibitors: know them to optimize their use in renal transplantation. 175
The impact of pruritus on quality of life of patients undergoing dialysis: A single-center cohort study 175
Can blood flow surveillance and pre-emptive repair of subclinical stenosis prolong the useful life of arteriovenous fistulae? A randomized controlled study 174
Prevalence of CKD in northeastern Italy: results of the INCIPE study and comparison with NHANES. 173
La qualità della vita nell’anziano in dialisi [Quality of life of the elderly patient on dialysis]. 172
Acute changes in renal function in IgA nephropathy 171
Epithelial to mesenchymal transition in the liver field: the double face of Everolimus in vitro. 171
Bedside Screening for Fistula Stenosis Should Be Tailored to the Site of the Arteriovenous Anastomosis 170
Metabolic Syndrome, Cardiovascular Disease, and Risk for Chronic Kidney Disease in an Italian Cohort: Analysis of the INCIPE Study. 170
Familial clustering of medullary sponge kidney is autosomal dominant with reduced penetrance and variable expressivity. 170
Sirolimus and Everolimus Pathway: Reviewing Candidate Genes Influencing Their Intracellular Effects 170
Impact of maintenance immunosuppressive therapy on the fecal microbiome of renal transplant recipients: Comparison between an everolimus- and a standard tacrolimus-based regimen. 168
Evaluation of hepcidin isoforms in hemodialysis patients by a proteomic approach based on SELDI-TOF MS 168
3 years' experience in the prevention of recurrent calcic nephrolithiasis 167
Systemic and Nonrenal Adverse Effects Occurring in Renal Transplant Patients Treated with mTOR Inhibitors. 167
Assessment of physical performance and body composition in male renal transplant patients 167
Monoclonal antibody therapy and renal transplantation: focus on adverse effects. 166
In search of an optimal bedside screening program for arteriovenous fistula stenosis 166
How has peritoneal dialysis changed over the last 30 years: experience of the Verona dialysis center 164
High chronic nephropathy detection yield in CKD subjects identified by the combination of albuminuria and estimated GFR. 163
A validated model of disease progression in IgA nephropathy. 162
Hepcidin is not useful as a biomarker for iron needs in haemodialysis patients on maintenance erythropoiesis-stimulating agents 162
GDNF gene Variants Associated with Medullary Sponge Kidney. Distinguish a Specific Clinical Phenotype. 161
Is it possible to use the identification of neutrophil gelatinase- associated lipocalin (NGAL) in the evaluation of bisphosphonates nephrotoxicity? [E' possibile utilizzare la determinazione della lipocalina associata alla gelatinasi dei neutrofili (NGAL) nella valutazione della nefrotossicità da bisfosfonati?] 161
Everolimus-induced epithelial to mesenchymal transition in immortalized human renal proximal tubular epithelial cells: key role of heparanase. 161
Carbohydrate metabolism in patients with nephrotic syndrome and normal renal function 160
Altered thyroid in dialysed uremic patients 159
Proteomic Analysis of Urinary Microvesicles and Exosomes in Medullary Sponge Kidney Disease and Autosomal Dominant Polycystic Kidney Disease. 159
Heparanase: A Potential New Factor Involved in the Renal Epithelial Mesenchymal Transition (EMT) Induced by Ischemia/Reperfusion (I/R) Injury. 159
Renal lesions after unilateral ureterosigmoidostomy in the rabbit: preliminary results 157
Antihypertensive, hemodynamic and endocrine effects of Captopril in arterial hypertension 157
Rapporti tra adattamento, qualità di vita e supporto familiare, sociale nel paziente in trattamento dialitico. [Dialysis, adaptation, quality of life, and family support.] 157
Unusual renal presentation of Fabry disease in a female patient. 157
In vitro effects of interleukin (IL)-1 beta inhibition on the epithelial-to-mesenchymal transition (EMT) of renal tubular and hepatic stellate cells. 157
Post-renal transplant pregnancy: a project to plan carefully 155
Mitochondria: a new therapeutic target in chronic kidney disease. 155
Genome-wide association studies identify genetic loci associated with albuminuria in diabetes. 155
Ten years experience of CAPD in diabetics: comparison of results with non-diabetics. Italian Cooperative Peritoneal Dialysis Study Group 153
ENDOTHELIAL PROGENITOR CELLS IN ACUTE RENAL INJURY 152
Sulodexide alone or in combination with low doses of everolimus inhibits the hypoxia-mediated epithelial to mesenchymal transition in human renal proximal tubular cells. 152
Safety and Efficacy of Citrate Anticoagulation for Continuous Renal Replacement Therapy for Acute Kidney Injury After Liver Transplantation: A Single-Center Experience. 152
mTOR Inhibition Role in Cellular Mechanisms 152
Red blood cells and platelet membrane fatty acids in non-dialyzed and dialyzed uremics 151
Cutaneous plasmacytoma in a hemodialysis patient. 151
Genetic associations at 53 loci highlight cell types and biological pathways relevant for kidney function. 151
Heparanase is a key player in renal fibrosis by regulating TGF-β expression and activity. 150
Personalization of the Immunosuppressive Treatment in Renal Transplant Recipients: The Great Challenge in "Omics" Medicine. 150
A type I interferon signature characterizes chronic antibody-mediated rejection in kidney transplantation. 149
Early dietary protein and phosphorus restriction is effective in delaying progression of chronic renal failure 148
Basi scientifiche per la definizione di linee guida in ambito clinico per i tumori della prostata 148
Pharmacogenetics: a promising tool to personalize immunosuppressive therapy in renal transplantation. 148
Renal tubular defects in recurring bilateral nephrolithiasis 147
Effects of high doses of frusemide on plasma and muscle electrolytes in patients with chronic renal failure 147
Procalcitonin values after dialysis is closely related to type of dialysis membrane 147
Should current criteria for detecting and repairing arteriovenous fistula stenosis be reconsidered? Interim analysis of a randomized controlled trial 147
Precocious activation of genes of the renin-angiotensin system and the fibrogenic cascade in IgA glomerulonephritis. 146
Practice patterns in the management of arteriovenous fistula stenosis: a northern Italian survey. 146
Heparanase regulates the M1 polarization of renal macrophages and their crosstalk with renal epithelial tubular cells after ischemia/reperfusion injury 146
Mantenimento del trapianto renale: impatto clinico a lungo termine di tre diversi protocolli immunosoppressivi Risultati di un ampio studio multicentrico italiano 146
Early small creatinine shift predicts contrast-induced acute kidney injury and persistent renal damage after percutaneous coronary procedures 146
Sclerostin and Dickkopf-1 in post-menopausal renal allograft recipients. 144
Transcriptomics: A Step behind the Comprehension of the Polygenic Influence on Oxidative Stress, Immune Deregulation, and Mitochondrial Dysfunction in Chronic Kidney Disease. 144
Medullary sponge kidney (Lenarduzzi-Cacchi-Ricci disease): A Padua Medical School discovery in the 1930s. 143
Dialysis-related transcriptomic profiling: The pivotal role of heparanase. 143
Totale 17.250
Categoria #
all - tutte 113.950
article - articoli 104.069
book - libri 0
conference - conferenze 4.609
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 5.272
Totale 227.900


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021573 0 0 0 0 0 0 0 0 0 17 323 233
2021/20221.677 96 363 18 178 64 52 39 113 88 50 150 466
2022/20234.371 328 426 471 662 419 1.100 53 267 444 23 121 57
2023/20241.717 99 176 163 198 235 231 27 117 16 76 261 118
2024/20254.810 312 351 174 825 225 160 194 269 729 290 375 906
2025/202612.753 1.060 696 913 2.121 3.199 961 1.435 754 899 715 0 0
Totale 36.060